Evidence map›Paper›PMID 28738817›Full record

ArticleBMC infectious diseases2017

Exacerbation of bronchiectasis by Pseudomonas monteilii: a case report.

Aditi, Malini Shariff, Kiran Beri

Abstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Beyond the Usual Suspects: EmergingInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Foods (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Creatine utilization as a sole nitrogen source inMicrobiology (Reading, England) · 2022
    Article
  9. Article
  10. Review
  11. Extensively drug-resistant IMP-16-producing Pseudomonas monteilii isolated from cerebrospinal fluid.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

AditiDepartment of Microbiology, Vallabhbhai Patel Chest Institute, North Campus, University of Delhi, Delhi, 110007, India.
Malini ShariffDepartment of Microbiology, Vallabhbhai Patel Chest Institute, North Campus, University of Delhi, Delhi, 110007, India. malini.shariff@gmail.com.ORCID 0000-0003-2226-8529
Kiran BeriDepartment of Microbiology, Vallabhbhai Patel Chest Institute, North Campus, University of Delhi, Delhi, 110007, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPseudomonas spp are important opportunistic and nosocomial pathogens. One such species is Pseudomonas monteilii (P. monteilii). It has been described as an environmental contaminant and potential pathogen. We identified this organism as the causative agent of an exacerbation of bronchiectasis and an environmental contaminant in our hospital on two separate occasions. CASE PRESENTATION: P. monteilii was the cause of an exacerbation of bronchiectasis in a 30-year-old HIV negative male. Patient presented with cough with sputum production and exertional dyspnea. The isolate was recovered from a sputum sample in significant counts and definitively identified by Matrix-Assisted Laser Desorption/Ionisation- Time of Flight Mass Spectrometry (MALDI-TOF MS). He was treated with piperacillin-tazobactam and recovered clinically and microbiologically. Another two isolates of the organism were contaminants from the hospital environment. The three isolates were susceptible to all tested antibiotics. Typing by Random amplification of polymorphic DNA (RAPD) found no clonal relationship between them.

conclusionsLess common species of Pseudomonas need to be identified accurately. This organism is identified by commonly used phenotypic systems as P. putida which may have contributed to a lower reported prevalence. P. monteilii is a known environmental contaminant and must also be considered as a potential pathogen, particularly in patients with chronic lung disease.

Indexed as

AdultBronchiectasisHumansMalePenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationPseudomonasPseudomonas InfectionsRandom Amplified Polymorphic DNA TechniqueSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationPenicillanic AcidPiperacillinPiperacillin, Tazobactam Drug CombinationBronchiectasisMALDI-TOF MSPseudomonas monteiliiPseudomonas putidaRAPD

Identifiers

PMID28738817
PMCPMC5525215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.